Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias II: Classification of Tachyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Dysrhythmias V: Evaluating Dysrhythmias
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 8, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Silvia G Priori1, Carlo Napolitano1
1Molecular Cardiology, ICS Maugeri and Deptartment of Molecular Medicine, University of Pavia, Pavia, Italy.
No abstract available in PubMed .